Merck & Co. Stock - weekly review and pharma peer comparison

Merck & Co. stock ends the week in a narrow range as investors reassess big pharma against peers like Pfizer, Bristol Myers Squibb and Johnson & Johnson. A modest 1-month gain contrasts with softer moves elsewhere in the sector.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 20:40 UTC. Details in the imprint.

Merck & Co. (US58933Y1055) remains one of the larger names in global pharmaceuticals by market value. The stock finishes this week broadly stable while investors reassess big pharma after mixed moves across the sector, according to MarketBeat data.

How Merck traded this week

Merck & Co. shares last closed at $114.04 on the New York Stock Exchange on 06/18/2026, with after-hours indications at $114.07 that evening, according to MarketBeat price data.

Over the past 30 days, Merck stock is up about 0.9%, a modest advance that points to a steady tape rather than aggressive repositioning in either direction.

Weekly review and peer comparison

Merck’s market capitalization stands near $281.6 billion, putting it firmly in the large-cap pharma bracket alongside Pfizer, Johnson & Johnson and Bristol Myers Squibb, based on MarketBeat figures.

While Merck posted a small gain over the past month, several big-pharma peers showed more volatile swings as investors reacted to pipeline headlines and pricing debates, according to sector overviews from MarketBeat.

The product behind the stock

Merck generates most of its revenue from prescription medicines and vaccines, with cancer therapy Keytruda and human papillomavirus vaccine Gardasil among its best-known products, as summarized in company and analyst profiles.

Where the stock trades today

The shares of Merck & Co. (US58933Y1055) trade on the New York Stock Exchange at $114.04 as of 06/18/2026, 15:59 Eastern Time.

Key facts on Merck & Co. stock

• Company: Merck & Co., Inc.
• ISIN: US58933Y1055
• WKN: A3DCV6
• Ticker: MRK
• Venue: NYSE
• Price (as of 06/18/2026, 15:59 Eastern Time): 114.04 USD
• Market cap: 281.65 billion USD (as of 06/18/2026)
• Sector / Industry: Health Care / Pharmaceuticals
• Index membership: Standard & Poor's 500 index
• Next earnings date: 07/28/2026

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.